Peter Jeffrey Snyder, Ph.D.

2008-2018 Neurology Warren Alpert Medical School of Brown University, Providence, RI, United States 
 2018- Department of Biomedical & Pharmaceutical Sciences The University of Rhode Island 
Neuropsychology, Neuropharmacology, Alzheimer's Disease, History of Neuroscience, Bioethics, Neurophysiology
"Peter J. Snyder"

Clinical neuropsychologist & neuroscientist, with initial specialty in epilepsy; Associate Prof. of Neurology, MCP & Hahnemann School of Medicine, Pittsburgh, 1994-1998; clinical drug development & discovery of novel biomarkers of neurodegenerative diseases progression - clinician at Pfizer Inc from 1998-2005; Professor of Psychology & Neurology, Univ. of Connecticut, 2005-2008; Visiting Professor, Yale Child Study Center, 2005 - present; Sr. Vice President & Chief Research Officer, Lifespan Hospitals System, Providence, RI, 2008 - 2018; Professor of Clinical Neuroscience (Neurology), Warren Alpert Medical School of Brown University, Providence, RI, 2008 - 2018. Vice President for Research & Professor of Biomedical and Pharmaceutical Sciences, The University of Rhode Island, Kingston, RI, 2018 - present. Scholar-in-Residence, The Rhode Island School of Design, Providence, RI., 2009 - present.

Mean distance: 15.92 (cluster 23)
Cross-listing: PsychTree - Alzheimer's Tree - History of History Tree


Sign in to add mentor
Jill B. Becker research assistant 1984-1986 University of Michigan
 (Undergraduate Honours Thesis Advisor)
Charles Butter research assistant 1984-1986 University of Michigan
 (Undergrad. advisor and Prof. for several courses)
William B. Barr grad student NYU School of Medicine
Lauren Julius Harris grad student 1986-1991 Michigan State
 (Major Professor & Doctoral Committee Chair)
Robert M. Bilder post-doc 1992-1994 Albert Einstein
 (Clinical Neuroscience Post-Doc Fellow)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Alber J, Maruff P, Santos CY, et al. (2020) Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval. Alzheimer's Research & Therapy. 12: 31
Alber J, Goldfarb D, Thompson LI, et al. (2020) Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 229-243
Dang C, Yassi N, Harrington KD, et al. (2019) Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 566-575
Bransby L, Lim YY, Ames D, et al. (2019) Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-10
Yilmaz T, Jutten RJ, Santos CY, et al. (2018) Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 161-164
Hampel H, Mesulam MM, Cuello AC, et al. (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain : a Journal of Neurology
Santos CY, Johnson LN, Sinoff SE, et al. (2018) Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 196-209
Alber J, McGarry K, Noto RB, et al. (2018) Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study. Frontiers in Aging Neuroscience. 10: 60
Klinger RY, James OG, Borges-Neto S, et al. (2018) 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology
Hampel H, Mesulam MM, Cuello AC, et al. (2017) Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
See more...